封面
市场调查报告书
商品编码
1748742

医疗模拟市场-全球产业规模、份额、趋势、机会和预测,按产品与服务、技术、最终用途、地区和竞争细分,2020-2030 年

Medical Simulation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Technology, By End-use, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 187 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年,全球医学模拟市场规模达20.5亿美元,预计2030年将以7.05%的复合年增长率成长。医学模拟涵盖运用先进技术和教育方法,复製真实的医疗场景,使医护人员能够在安全可控的环境中实践。它是提升临床技能、决策能力和团队协作能力的重要工具,且不会危害病人安全。全球医疗体系面临严重的劳动力短缺——世界卫生组织预测到2030年将出现1,000万名医护人员的缺口──基于模拟的教育变得日益重要。这些解决方案在增强医疗人员能力、改善患者预后以及在先进和资源匮乏的环境中扩大优质培训覆盖面方面发挥着至关重要的作用。

市场概览
预测期 2026-2030
2024年市场规模 20.5亿美元
2030年市场规模 30.6亿美元
2025-2030 年复合年增长率 7.05%
成长最快的领域 程序演练技术
最大的市场 北美洲

关键市场驱动因素

技术进步

主要市场挑战

初始投资成本高

主要市场趋势

虚拟实境 (VR) 和扩增实境 (AR) 集成

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球医学模拟市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品和服务(医疗解剖模型、基于网路的模拟器、医疗模拟软体、模拟训练服务)
    • 依技术分类(虚拟病人模拟、3D列印、手术演练技术)
    • 依最终用途(学术机构、医院、军事组织、研究)
    • 按地区(北美、欧洲、亚太、南美、中东和非洲)
    • 按公司分类(2024)
  • 产品市场图
    • 按产品和服务
    • 依技术
    • 按最终用途
    • 按地区

第六章:北美医学模拟市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲医学模拟市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太医学模拟市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲

第九章:南美洲医学模拟市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲医学模拟市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 合併与收购
  • 产品开发
  • 最新动态

第 13 章:波特的分析

第 14 章:PESTEL 分析

第 15 章:竞争格局

  • CAE (Canadian Aviation Electronics, Ltd)
  • Laerdal Medical Corp.
  • 3D SystemsInc.
  • Simulab Corporation
  • Limbs & Things Ltd
  • Simulaids Inc.
  • Kyoto Kagaku Co., Ltd
  • Gaumard Scientific Company Inc.
  • Mentice AB
  • Surgical Science Sweden AB

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 16196

The Global Medical Simulation Market was valued at USD 2.05 billion in 2024 and is projected to grow at a CAGR of 7.05% through 2030. Medical simulation encompasses the use of advanced technologies and educational methodologies to replicate real-life medical scenarios, allowing healthcare professionals to practice in a safe and controlled environment. It serves as a vital tool for enhancing clinical skills, decision-making, and team coordination without risking patient safety. As healthcare systems globally face severe workforce shortages-highlighted by WHO's projection of a 10 million healthcare professional shortfall by 2030-simulation-based education becomes increasingly essential. These solutions play a crucial role in strengthening workforce capabilities, improving patient outcomes, and expanding access to quality training across both advanced and resource-limited settings.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.05 Billion
Market Size 2030USD 3.06 Billion
CAGR 2025-20307.05%
Fastest Growing SegmentProcedure Rehearsal Technology
Largest MarketNorth America

Key Market Drivers

Advancements in Technology

Technological advancements are a key driver accelerating the Global Medical Simulation Market. Emerging tools such as virtual reality (VR), augmented reality (AR), high-fidelity manikins, and haptic feedback systems are transforming medical education by creating immersive, interactive environments for training. These innovations offer realistic simulations for complex clinical procedures, diagnostics, and emergency scenarios. For instance, the Irish government launched a free VR learning program in December 2023 for nursing education, developed by the University of Galway under the ERASMUS+ initiative. Similarly, Limbs & Things Ltd acquired eoSurgical in July 2023 to expand its capabilities in laparoscopic training. Such technological integrations enable personalized, remote, and highly effective training modules, broadening access and raising the standard of medical education globally.

Key Market Challenges

High Initial Investment Costs

One of the primary challenges in the Global Medical Simulation Market is the high upfront cost associated with acquiring and implementing advanced simulation technologies. High-fidelity simulators, VR/AR platforms, and custom software systems require significant capital investment. Expenses also include infrastructure development, hardware setup, training of personnel, and ongoing system maintenance. Smaller institutions, especially in developing regions, often face budgetary constraints that limit adoption. Additionally, the need for continuous updates to keep pace with evolving medical protocols adds to the financial burden. Despite these challenges, the long-term benefits-such as enhanced clinical competencies, reduced medical errors, and improved patient safety-offer substantial return on investment. Collaborative programs, grants, and resource-sharing models are helping mitigate cost barriers and making simulation tools more accessible.

Key Market Trends

Virtual Reality (VR) and Augmented Reality (AR) Integration

The integration of Virtual Reality (VR) and Augmented Reality (AR) has emerged as a transformative trend in medical simulation. VR immerses users in realistic digital environments for practicing surgical techniques, diagnostics, and emergency responses, while AR overlays real-world scenarios with digital data like anatomical visuals and procedural instructions. This blend enhances experiential learning, spatial awareness, and decision-making. It also facilitates remote collaboration and standardized training regardless of geographic location. With ongoing technological refinement, VR and AR are becoming more accessible and cost-effective, enabling their wider adoption across academic institutes, hospitals, and military healthcare training centers. Their growing use is setting a new standard for medical education and simulation-based clinical preparedness.

Key Market Players

  • CAE (Canadian Aviation Electronics, Ltd)
  • Laerdal Medical Corp.
  • 3D Systems Inc.
  • Simulab Corporation
  • Limbs & Things Ltd
  • Simulaids Inc.
  • Kyoto Kagaku Co., Ltd
  • Gaumard Scientific Company Inc.
  • Mentice AB
  • Surgical Science Sweden AB

Report Scope:

In this report, the Global Medical Simulation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Simulation Market, By Product & Services:

  • Healthcare Anatomical Models
  • Web-based Simulator
  • Healthcare Simulation Software
  • Simulation Training Services

Medical Simulation Market, By Technology:

  • Virtual Patient Simulation
  • 3D Printing
  • Procedure Rehearsal Technology

Medical Simulation Market, By End Use:

  • Academic Institutes
  • Hospitals
  • Military Organizations
  • Research

Medical Simulation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Simulation Market.

Available Customizations:

Global Medical Simulation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Types
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Medical Simulation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Services (Healthcare Anatomical Models, Web-based Simulators, Healthcare Simulation Software, Simulation Training Services)
    • 5.2.2. By Technology (Virtual Patient Simulation, 3D Printing, Procedure Rehearsal Technology)
    • 5.2.3. By End-use (Academic Institutes, Hospitals, Military Organizations, Research)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Product & Services
    • 5.3.2. By Technology
    • 5.3.3. By End Use
    • 5.3.4. By Region

6. North America Medical Simulation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Services
    • 6.2.2. By Technology
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Medical Simulation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Medical Simulation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Medical Simulation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By End Use

7. Europe Medical Simulation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services
    • 7.2.2. By Technology
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Medical Simulation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Medical Simulation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Medical Simulation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Medical Simulation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Medical Simulation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
      • 7.3.5.3. By Product & Services
      • 7.3.5.4. By Technology
      • 7.3.5.5. By End Use

8. Asia-Pacific Medical Simulation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services
    • 8.2.2. By Technology
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Medical Simulation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By End Use
    • 8.3.2. Japan Medical Simulation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By End Use
    • 8.3.3. India Medical Simulation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Medical Simulation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Medical Simulation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By End Use

9. South America Medical Simulation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services
    • 9.2.2. By Technology
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Medical Simulation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Medical Simulation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Medical Simulation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Medical Simulation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services
    • 10.2.2. By Technology
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Medical Simulation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Medical Simulation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By End Use
    • 10.3.3. South Africa Medical Simulation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition
  • 12.2. Product Development
  • 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

  • 15.1. CAE (Canadian Aviation Electronics, Ltd)
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
  • 15.2. Laerdal Medical Corp.
  • 15.3. 3D SystemsInc.
  • 15.4. Simulab Corporation
  • 15.5. Limbs & Things Ltd
  • 15.6. Simulaids Inc.
  • 15.7. Kyoto Kagaku Co., Ltd
  • 15.8. Gaumard Scientific Company Inc.
  • 15.9. Mentice AB
  • 15.10. Surgical Science Sweden AB

16. Strategic Recommendations

17. About Us & Disclaimer